Leizorovicz A, Turpie A G G, Cohen A T, Wong L, Yoo M C, Dans A
Service de Pharmacologie Clinique, EA 3736, Université de Lyon 1, Lyon, France.
J Thromb Haemost. 2005 Jan;3(1):28-34. doi: 10.1111/j.1538-7836.2004.01094.x.
In Asian patients undergoing surgery, the incidence of venous thromboembolism (VTE) is thought to be low relative to Western patients, and the routine use of thromboprophylaxis is controversial.
The aim of this work was to study the epidemiology of VTE in Asian patients undergoing orthopedic surgery without thromboprophylaxis.
We performed a prospective observational study of a cohort of consecutive Asian patients hospitalized for total hip or knee replacement or hip fracture surgery without thromboprophylaxis. The primary study outcome was the incidence of the composite of symptomatic VTE or sudden death at hospital discharge. This outcome was also assessed at 1 month's follow-up.
Between April 2001 and July 2002, 2420 patients were enrolled. Median age was 68 years and the median duration of hospital stay was 13 days. The rate of symptomatic VTE or sudden death as notified by investigators was 2.3%[55 patients, 99% confidence interval (CI) 1.6, 3.2] and 1.2% (28 patients, 99% CI 0.7, 1.8) after adjudication by an independent committee. Chronic heart failure, varicose veins and a history of VTE were independent risk factors (P < 0.05) for the occurrence of the primary endpoint. At 1 month's follow-up, the incidence of adjudicated symptomatic VTE or sudden death was 1.5% (35/2264 patients).
In Asian patients, the incidence of symptomatic VTE after major orthopedic surgery is not low, consistent with the rates observed in Western countries. The use of thromboprophylaxis should be considered in Asian patients undergoing such high-risk surgical procedures.
在接受手术的亚洲患者中,静脉血栓栓塞症(VTE)的发生率被认为相对于西方患者较低,并且预防性使用血栓药物存在争议。
本研究旨在探讨未进行血栓预防的亚洲骨科手术患者中VTE的流行病学情况。
我们对一组连续住院接受全髋关节或膝关节置换术或髋部骨折手术且未进行血栓预防的亚洲患者进行了前瞻性观察研究。主要研究结局是出院时症状性VTE或猝死的复合发生率。该结局也在1个月随访时进行评估。
2001年4月至2002年7月期间,共纳入2420例患者。中位年龄为68岁,中位住院时间为13天。经独立委员会判定,研究者报告的症状性VTE或猝死发生率为2.3%[55例患者,99%置信区间(CI)1.6,3.2],判定后为1.2%(28例患者,99%CI 0.7,1.8)。慢性心力衰竭、静脉曲张和VTE病史是发生主要终点事件的独立危险因素(P<0.05)。在1个月随访时,判定的症状性VTE或猝死发生率为1.5%(2264例患者中的35例)。
在亚洲患者中,大型骨科手术后症状性VTE的发生率并不低,与西方国家观察到的发生率一致。对于接受此类高风险手术的亚洲患者,应考虑使用血栓预防措施。